J. Hedner (Gothenburg, Sweden), J. Verbraecken (Antwerp, Belgium)
Efficacy of and compliance to adaptative servo-ventilation (ASV) for sleep apnea syndrome (SAS) with cheyne-stokes respiration (CSR) in cardiologic versus non-cardiologic patients
M. Herman, C. Philippe, S. Rouault, L. Hittinger, X. Drouot, F. Goldenberg, M. P. D‘Ortho (Creteil, Paris, Puteaux, France)
|  |
Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration
E. Quintana, C. Carmona, A. Campos, A. Sanchez, E. Lage, F. Capote (Seville, Spain)
| |
Sleep and sleep disordered breathing following acute myocardial infarction
R. Staats, H. Romy, L. Wiebke, V. Wolfgang, N. Christoph, V. C. Johann (Rostock, Germany)
| |
AutoCPAP might work in treating sleep breathing disorders related to dilated hypokinetic myocardiopathy (SBDHM)
B. Langevin, J. Y. Bayle, T. Petitjean, G. Evers (Lyon, France)
| |
Hyperinsulinemia and insulinresistans in sleep apnea syndrom (SAS)
M. Rzymkowska, M. Kolaczkowska, T. Piorunek, S. Cofta (Poznan, Poland)
| |
Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea
C. Egea, J. Pinto, J. Ayuela, E. Ballester, C. Zamarron, A. Sojo, F. Barbe, HFCPAP Cooperative Group (Vitoria, Santander, Burgos, Barcelona, Compostela, Caceres, Mallorca, Spain)
| |
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome
I. M. Bardakci, H. Firat, Z. Dansuk, C. P. Tastan Dursun, P. Alagoz, Z. Yildirim, S. Ardic (Ankara, Turkey)
| |
Plasma antioxidant factors in persons with different stages of obstructive sleep apnea syndrome
S. Cofta, E. Wysocka, J. Gozdzik (Poznan, Poland)
| |
The use of heart rate variability in detecting sleep disordered breathing in patients with heart failure
A. Vazir, M. Dayer, R. H. Minnion, M. R. Cowie, P. A. Poole-Wilson, M. J. Morrell, A. K. Simonds (London, United Kingdom)
| |
Cardiovascular profile of modafinil: effects on blood pressure and heart rate
J. Sackner-Bernstein, G. Niebler, C. Q. Earl (Manhasset, West Chester, United States Of America)
| |
Sleep-disordered breathing in chronic kidney disease
N. K. Markou, M. H. Kanakaki, P. Myrianthefs, D. Hadjiyanakos, A. Mytioudi, D. Vlassopoulos, A. Damianos, K. Siamopoulos, M. Vasiliou, S. Konstantopoulos (Athens, Greece)
| |
Is tobacco smoking a risk factor for OSA: an epidemiological study
M. Bednarek, R. Plywaczewski, L. Jonczak, J. Zielinski (Warsaw, Poland)
| |
CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS)
K. Pagonidis, D. Tsetis, E. Lampiri, E. Argiana, N. Gourtsoyiannis, N. M. Siafakas, S. E. Schiza (Heraklion, Greece)
| |
Prevalence and severity of cardiac dysrhythmias correlate with echocardiographic findings in sleep apnoea/hypopnoea syndrome B
Z. Tomori, E. Szaboova, V. Donic (Kosice, Slovakia)
| |
Leptin daytime urine secretion corresponds to OSA severity
J. Chorostowska-Wynimko, R. Plywaczewski, L. Jonczak, E. Skopinska, J. Zielinski, D. Gorecka (Warsaw, Poland)
| |
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome
O. Kokturk, T. Ulukavak Ciftci, E. R. Han, B. Ciftci (Ankara, Turkey)
| |
Left ventricular geometry in patients with obstructive sleep apnea syndrome
O. Y. Chizhova, B. O. Terechenko (St Petersburg, Russia)
| |